Shanghai Zhuangming Biopharma Co., Ltd. (formerly Zhuangming Technology) is a high-tech enterprise dedicated to the R&D, production and sales of high-end organosilicon products. Its R&D base is located in Pudong, Shanghai, and its pilot and production bases are situated in Daren Industrial Park, Hechi City, Guangxi Zhuang Autonomous Region. The company focuses on the development and production of various new organosilicon monomers and high-end organosilicon polymers. Its product categories include alkylsilanes, halosilanes, aminosilanes, hydrosilanes, alkoxysilanes, unsaturated silanes; special silicone oils, silicone resins, silicone rubbers, coupling agents, crosslinking agents, photoresists, etc. Its business covers multiple fields such as biomedicine, high-end manufacturing, new energy, electronic consumption, photoresist, and OLED.

The company's Shanghai laboratory spans over 1,200 square meters, equipped with a full set of advanced synthesis and purification equipment. It focuses on synthesis design, route development and process optimization to lay a solid foundation for R&D innovation.
The laboratory is furnished with professional testing instruments, including GC (Gas Chromatography), HPLC (High Performance Liquid Chromatography), moisture analyzer and LC-MS (Liquid Chromatography-Mass Spectrometry). Meanwhile, it maintains long-term cooperation with multiple domestic professional testing institutions, enabling the provision of custom services ranging from gram-scale to kilogram-scale.
The company has a professional R&D team of over 30 technicians, with more than 1,500 developed compounds. It excels in special reactions such as Grignard reaction, hydrosilylation, coupling reaction, oxidation and hydrogenation reduction, and holds more than 20 invention patents.
In terms of academic cooperation, the company has established long-term technical partnerships with domestic scientific research institutions, including the Chinese Academy of Sciences, Shanghai University, Lanzhou Institute of Chemical Physics, Nanchang University and Hangzhou Normal University.

Hechi Zhuangming Biopharmaceutical Co., Ltd. is a wholly-owned manufacturing subsidiary of Shanghai Zhuangming. Covering an area of 80,000 square meters (120 mu), its Phase I project has a total reactor volume of 50,000 liters and supporting post-processing capacity, with an annual production capacity of over 1,000 tons; the Phase II project is currently in the project approval stage. The supply volume of its products ranges from hundreds of kilograms to hundreds of tons. Meanwhile, Hechi Zhuangming is equipped with pilot-scale equipment, featuring a reactor volume of 2,000 liters, which enables custom production with a capacity ranging from dozens of kilograms to hundreds of kilograms.
The company has established a production capacity service covering small-scale gram-level to ton-level. At present, the company maintains a regular inventory of more than 500 product types.

Over the past 10 years since its establishment, the company has grown and forged ahead, thanks to the trust and support of numerous outstanding customers and partners at home and abroad. In the future, Zhuangming will continue to rely on technological innovation and process innovation, deepen its presence in the niche field of special organosilicon monomers, enrich technical accumulation, consolidate process foundations, and continue to provide domestic and foreign customers with full-cycle services covering development, customization and production!